EMA Write PMS API Implementation Guide - Enrichments
1.0.0 - ci-build
EMA Write PMS API Implementation Guide - Enrichments - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2025-04-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="200000000324"/>
<meta>
<versionId value="5.0.0"/>
<lastUpdated value="2023-08-03T11:35:00.198Z"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem 200000000324</b></p><a name="200000000324"> </a><a name="hc200000000324"> </a><a name="200000000324-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 5.0.0; Last updated: 2023-08-03 11:35:00+0000</p></div><p>This case-sensitive code system <code>http://spor.ema.europa.eu/v1/lists/200000000324</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">200000003511<a name="200000000324-200000003511"> </a></td><td>Parallel Distributed/Imported medicinal product (Article 76(3) and (4) of Directive No 2001/83/EC)</td></tr><tr><td style="white-space:nowrap">200000003512<a name="200000000324-200000003512"> </a></td><td>Exceptional Circumstances Marketing Authorisation (Article 14(6) (8) of Regulation (EC) No 726/2004 or Article 22 of Directive 2001/83/EC)</td></tr><tr><td style="white-space:nowrap">200000003513<a name="200000000324-200000003513"> </a></td><td>Authorised homeopathic medicinal product</td></tr><tr><td style="white-space:nowrap">200000003514<a name="200000000324-200000003514"> </a></td><td>Authorised herbal medicinal product</td></tr><tr><td style="white-space:nowrap">200000003515<a name="200000000324-200000003515"> </a></td><td>Paediatric Use Marketing Authorisation (PUMA) (Article 30 of Regulation (EC) No 1901/2006)</td></tr><tr><td style="white-space:nowrap">200000003516<a name="200000000324-200000003516"> </a></td><td>Conditional Marketing Authorisation (Article 14 (7) of Regulation (EC) No 726/2004)</td></tr><tr><td style="white-space:nowrap">200000003517<a name="200000000324-200000003517"> </a></td><td>Other</td></tr></table></div>
</text>
<url value="http://spor.ema.europa.eu/v1/lists/200000000324"/>
<version value="1.0.0"/>
<name value="XevmpdMedicinalProductTypeCs"/>
<title value="XEVMPD Medicinal Product Type"/>
<status value="active"/>
<experimental value="false"/>
<date value="2025-04-04T16:15:09+01:00"/>
<publisher value="EMA"/>
<contact>
<name value="EMA"/>
<telecom>
<system value="url"/>
<value value="https://support.ema.europa.eu/esc"/>
</telecom>
</contact>
<description value="XEVMPD Medicinal Product Type"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="7"/>
<concept>
<code value="200000003511"/>
<display
value="Parallel Distributed/Imported medicinal product (Article 76(3) and (4) of Directive No 2001/83/EC)"/>
</concept>
<concept>
<code value="200000003512"/>
<display
value="Exceptional Circumstances Marketing Authorisation (Article 14(6) (8) of Regulation (EC) No 726/2004 or Article 22 of Directive 2001/83/EC)"/>
</concept>
<concept>
<code value="200000003513"/>
<display value="Authorised homeopathic medicinal product"/>
</concept>
<concept>
<code value="200000003514"/>
<display value="Authorised herbal medicinal product"/>
</concept>
<concept>
<code value="200000003515"/>
<display
value="Paediatric Use Marketing Authorisation (PUMA) (Article 30 of Regulation (EC) No 1901/2006)"/>
</concept>
<concept>
<code value="200000003516"/>
<display
value="Conditional Marketing Authorisation (Article 14 (7) of Regulation (EC) No 726/2004)"/>
</concept>
<concept>
<code value="200000003517"/>
<display value="Other"/>
</concept>
</CodeSystem>